ArticleJournal of kidney cancer and VHL2020

Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation.

Panagiotis J VlachostergiosPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.